Roivant Company Profile, Contacts & Intelligence
Roivant Overview
Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs. In addition to our biopharmaceutical subsidiaries, we also build technology-focused Vants focused on improving the process of developing and commercializing medicines.
- Headquarters
- Ch
- Website
- www.roivant.com
- Industry
- Biotechnology
Roivant Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Roivant People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Compare Similar Companies to Roivant
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Vertex Pharmaceuticals | Biotechnology Research | 6.09K | View company |
| PTC Therapeutics, Inc. | Biotechnology Research | 1.18K | View company |
| Travere Therapeutics | Biotechnology | 438 | View company |
| SpringWorks Therapeutics | Biotechnology Research | 418 | View company |
| Immunovant | Biotechnology Research | 362 | View company |
| Strive | Financial Services | 129 | View company |
| Priovant Therapeutics | Biotechnology Research | 70 | View company |
| VantAI | Biotechnology | 70 | View company |
| QVT Financial LP | Investment Management | 36 | View company |
| Pulmovant | Biotechnology Research | 34 | View company |